Ongoing monitoring then includes symptom assessment and enzyme checks at intervals, with patient education on warning signs such as epigastric pain, nausea, or elevated triglycerides
SOURCE Innovent Biologics
In addition to a reported focus on labeling in hypothalamic obesity, PL7737 was granted Orphan Drug Designation status by the U.S
Science-backed weight loss In clinical studies using Saxenda, results showed that over 52 weeks (12 months)
Obesity-associated cancers include prostate, ovarian, breast (post-menopausal), colorectal, endometrial, and renal cancers [8]
Patients should be advised to source any compounded products from reputable pharmacies that follow USP sterile compounding standards